Ipilimumab-induced reactions of the respiratory tract and renal system.

*case is detailed in the result section. alisted treatments are systemic treatments unless otherwise specified. btumor-free high-risk stage III melanoma (AJCC 2009); adjuvant administration of ipilimumab. cstage IV metastatic disease (AJCC 2009). dPRAME study; vaccination with GSK2302025A. eatypical pneumonia. facute renal failure. grenal failure/atypical pneumonia. hiridocyclitis/keratitis, deafness. Irenal failure/atypical pneumonia/iridocyclitis/keratitis. jdeafness. M indicates male; F, female; LN, lymph nodes; IFN-α, interferon-α; DTIC, dacarbazine; DVP; polychemotherapy with dacarbazine/vindesine/paclitaxel; GIT, gastrointestinal tract; PR, partial response; SD, stable disease; MR, mixed response; PD, progressive disease.